About ICE Pharma
ICE Pharma is a company based in Alessandria (Italy) founded in 1949. The company has 210 employees as of April 06, 2024. ICE Pharma offers products and services including Ursodeoxycholic Acid, CDMO Services, Finished Dosage Forms, and Nutraceutical Supplements. ICE Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
- Headquarter Alessandria, Italy
- Employees 210 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Raichem Medicare Private Limited
- Date of Incorporation 01 Jun, 2009
- Jurisdiction Chicksugur Village, Karnataka, India
-
Annual Revenue
$59.95 M (USD)10.91as on Mar 31, 2023
-
Net Profit
$1.25 M (USD)-42.58as on Mar 31, 2023
-
EBITDA
$4.85 M (USD)4.15as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
210
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ICE Pharma
ICE Pharma offers a comprehensive portfolio of products and services, including Ursodeoxycholic Acid, CDMO Services, Finished Dosage Forms, and Nutraceutical Supplements.
Key ingredient for liver disease treatments in pharmaceuticals
Development and production services for pharmaceutical products
Ready-to-use formulations for various medical applications
Branded items focused on immune and gut health support
People of ICE Pharma
Unlock access to complete
Funding Insights of ICE Pharma
Detailed funding history for ICE Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ICE Pharma
Investment portfolio details for ICE Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ICE Pharma
Detailed financials for ICE Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ice Pharma Comparisons
Peer comparison for ICE Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ICE Pharma
ICE Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are manufactured and custom synthesis services are provided.
|
Detailed competitors of ICE Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ice Pharma
Complete news archive for ICE Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ICE Pharma
ICE Pharma was founded in 1949.
ICE Pharma is headquartered in Alessandria, Italy. It is registered at Alessandria, Piedmont, Italy.
Agostino Barazza is the current CEO of ICE Pharma.
As of Apr 06, 2024, the latest employee count at ICE Pharma is 210.
Annual revenue of ICE Pharma is $59.95M as on Mar 31, 2023.
ICE Pharma was established in 1949 in Alessandria, Italy, where operations as a Contract Development and Manufacturing Organization (CDMO) are conducted. Focus is placed on the production of active pharmaceutical ingredients (API) for the pharmaceutical sector. Services encompass development and manufacturing processes tailored to client specifications. The company maintains its primary facility in Italy, supporting pharmaceutical supply chains across various markets.
ICE Pharma's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
ICE Pharma offers Ursodeoxycholic Acid, CDMO Services, Finished Dosage Forms, and Nutraceutical Supplements.